Introduction Abortion providers may be reluctant to commence abortion before ultrasound
evidence of intrauterine pregnancy (IUP) due to concerns of missed ectopic pregnancy. In …

“Very early medical abortion”(VEMA) refers to medical abortion (with mifepristone and
misoprostol) before intrauterine pregnancy is visualized on ultrasound. Our aim is to present …

Abortion legislation in the British Isles is fragmented and no longer fit for purpose. In
Scotland, recent changes in the application of the 1967 Abortion Act have improved care for …

Abstract Introduction: The combination Mifepristone and Misoprostol for medical abortion of
early first-trimester pregnancy has been approved by Health Canada since 2016. However …

Objective To evaluate outcomes with mifepristone 200 mg orally followed 24–48 h later by
misoprostol 800 mcg vaginally for medical abortion at 64–70 days of gestation. Study design …

A very early medical abortion (VEMA) is an abortion early in pregnancy before the
pregnancy is visible on an ultrasound. This treatment has been offered in several countries …

Background and methodology This survey was undertaken to obtain the opinions of women
in the UK about their home management of early medical abortion (EMA) with mifepristone …

Early medical abortion (EMA)(ie, using combination mifepristone and misoprostol to
terminate pregnancies of less than 10 weeks' gestation) is the the most common method of …

Objectives The objectives were to evaluate the safety and acceptability of outpatient medical
abortion in selected women without a pretreatment ultrasound or pelvic examination. Study …

BACKGROUND: The study was conducted to assess the effectiveness of early medical
abortion (EMA) in women with early pregnancy and no defined intrauterine gestational sac …